In all GC tumors, higher IDO1 expression was significantly observed in less advanced stages, corresponding to absence of lymphatic invasion (×6.3, p = 0.005) and lower TNM stages (I and II, ×3.2, p = 0.036) (Table 4). This evidence concerns the gene IDO1 and gastric cancer.